{
    "clinical_study": {
        "@rank": "151258", 
        "arm_group": [
            {
                "arm_group_label": "Stress reduction program", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Attention control", 
                "arm_group_type": "Other"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the effects of a stress reduction program on the\n      quality of life of ovarian cancer patients during primary adjuvant chemotherapy."
        }, 
        "brief_title": "Stress Reduction in Ovarian Cancer", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Ovarian, Fallopian, and Primary Peritoneal Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Ovarian Neoplasms", 
                "Peritoneal Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects must have an initial diagnosis of ovarian, fallopian tube or primary\n             peritoneal cancer who completed primary ovarian cancer surgery or 3 cycles of\n             neoadjuvant chemotherapy with interval cytoreductive surgery (ICS).\n\n          -  Final pathology diagnosis of stage I-IV ovarian, fallopian tube or primary peritoneal\n             cancer with plan to receive primary adjuvant chemotherapy or completion of\n             chemotherapy after ICS.\n\n          -  Receive chemotherapy at the University of Wisconsin-Madison.\n\n          -  Subjects must be at least 18 years of age.\n\n          -  English-speaking\n\n          -  Subjects must be able to use audio media, and read and understand the study manual.\n\n          -  ECOG performance status 0-2.\n\n          -  Subjects must have a phone.\n\n        Exclusion Criteria:\n\n          -  Subjects participating in a meditation practice more than 1 hour per week prior to\n             surgery and/or chemotherapy administration.\n\n          -  Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer.\n\n          -  Subjects with diagnosis of Chronic Fatigue Syndrome (CFS).\n\n          -  Subjects unable to use audio media due to auditory dysfunction.\n\n          -  Subjects unable to read written English.\n\n          -  Subjects who are prisoners or incarcerated."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01790789", 
            "org_study_id": "2013-0027", 
            "secondary_id": "OS12706"
        }, 
        "intervention": [
            {
                "arm_group_label": "Stress reduction program", 
                "description": "Subjects will participate in activities of a daily stress reduction program.", 
                "intervention_name": "Daily stress reduction program", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Attention control", 
                "description": "Subjects will receive periodic phone calls to review study protocol and will receive stress reduction program materials at the end of the study.", 
                "intervention_name": "Attention control", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 14, 2014", 
        "location": {
            "contact": {
                "last_name": "Cancer Connect", 
                "phone": "800-622-8922"
            }, 
            "contact_backup": {
                "last_name": "Sarah Stewart", 
                "phone": "608-263-0796"
            }, 
            "facility": {
                "address": {
                    "city": "Madison", 
                    "country": "United States", 
                    "state": "Wisconsin", 
                    "zip": "53792"
                }, 
                "name": "University of Wisconsin School of Medicine and Public Health"
            }, 
            "investigator": [
                {
                    "last_name": "Stephen Rose, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ryan Spencer, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Stress Reduction During Primary Adjuvant Chemotherapy for Ovarian Cancer", 
        "overall_contact": {
            "email": "cancerconnect@uwcarbone.wisc.edu", 
            "last_name": "Cancer Connect", 
            "phone": "800-622-8922"
        }, 
        "overall_contact_backup": {
            "last_name": "Sarah Stewart", 
            "phone": "608-263-0796"
        }, 
        "overall_official": {
            "affiliation": "University of Wisconsin, Madison", 
            "last_name": "Stephen Rose, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Fatigue will be measured using the NIH PROMIS Cancer Fatigue survey instrument", 
            "measure": "Fatigue", 
            "safety_issue": "No", 
            "time_frame": "18 weeks (completion of chemotherapy)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01790789"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Cytotoxicity assays will be conducted to determine if the meditation-based intervention results in an increase in the ability of the NK cells to recognize and lyse cancer targets.", 
            "measure": "Natural Killer Cell Activity", 
            "safety_issue": "No", 
            "time_frame": "18 weeks (completion of chemotherapy)"
        }, 
        "source": "University of Wisconsin, Madison", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Wisconsin, Madison", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}